Velcade pulbere pentru solutie injectabila 3,5 mg Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

velcade pulbere pentru solutie injectabila 3,5 mg

janssen-cilag international nv - bortezomibum - pulbere pentru solutie injectabila - 3,5 mg

AMOXICILINA/ACID CLAVULANIC KRKA 400 mg/57 mg/5 ml Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

amoxicilina/acid clavulanic krka 400 mg/57 mg/5 ml

krka, d.d., novo mesto - slovenia - kalii + acid clavulanicum - pulb. pt. susp. orala - 400mg/57mg/5ml - antibiotice beta-lactamice, peniciline peniciline in combinatii incl. inhibitori de betalactamaza

PRENESSA 4 mg Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prenessa 4 mg

krka, d.d., novo mesto - slovenia - perindoprilum - compr. orodispersabile - 4mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

PRENESSA 8 mg Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prenessa 8 mg

krka, d.d., novo mesto - slovenia - perindoprilum - compr. orodispersabile - 8mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

DONASERTONE 20 micrograme/24 ore Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

donasertone 20 micrograme/24 ore

odyssea pharma sprl - belgia - levonorgestrelum - sist. cu cedare intrauterina - 20 micrograme/24 ore - contraceptive locale contraceptive locale

Yesafili Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologice - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.